| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |